Literature DB >> 8625774

Hepatic iron contents and response to interferon-alpha in patients with chronic hepatitis C. Relationship to genotypes of hepatitis C virus.

N Izumi1, N Enomoto, M Uchihara, T Murakami, K Ono, O Noguchi, S Miyake, T Nouchi, K Fujisawa, F Marumo, C Sato.   

Abstract

Recent reports have shown that response to interferon treatment is influenced by hepatic iron contents in patients with chronic hepatitis C. In those reports, however, hepatitis C virus (HCV) genotypes and serum HCV-RNA levels were not examined. The aim of the present study was to investigate whether hepatic iron contents influence the response to interferon in patients with chronic hepatitis C and whether HCV genotypes and serum HCV-RNA levels play a role in this relationship. Among 65 patients with chronic hepatitis C, hepatic iron contents were significantly high in patients with a history of excess drinking of alcohol (more than 80 g/day) compared to those without, and significantly low in female patients before menopause. Having excluded these patients, hepatic iron contents were significantly higher in patients with genotype 1b infection than those with genotype 2a and 2b infection. There was no significant correlation between hepatic iron contents and plasma HCV-RNA levels. Among the patients with genotype 1b infection, hepatic iron contents were significantly lower in the responders to interferon than those in the nonresponders (429 +/- 100 vs 875 +/- 110 micrograms/g liver, P < 0.05). From these results, it is concluded that response to interferon is mainly influenced by HCV genotypes, while hepatic iron contents may play an important role in response to interferon in patients with genotype 1b infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8625774     DOI: 10.1007/bf02091542

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  24 in total

1.  Hemochromatosis, chondrocalcinosis, and hepatitis C.

Authors:  H S Nemser; H S Hammerman
Journal:  Hosp Pract (Off Ed)       Date:  1991-04

2.  Iron overload and response to alpha-interferon in chronic hepatitis C.

Authors:  C M Girelli; C Mirata; E Lesinigo; A Casiraghi
Journal:  Am J Gastroenterol       Date:  1995-01       Impact factor: 10.864

3.  Measurements of iron status in patients with chronic hepatitis.

Authors:  A M Di Bisceglie; C A Axiotis; J H Hoofnagle; B R Bacon
Journal:  Gastroenterology       Date:  1992-06       Impact factor: 22.682

4.  Iron reduction therapy: simply camouflage, or a real weapon?

Authors:  P Caraceni; S Fagiuoli; D H Van Thiel
Journal:  Am J Gastroenterol       Date:  1994-07       Impact factor: 10.864

5.  Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.

Authors:  G L Davis; L A Balart; E R Schiff; K Lindsay; H C Bodenheimer; R P Perrillo; W Carey; I M Jacobson; J Payne; J L Dienstag
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

6.  Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

Authors:  J Y Lau; G L Davis; J Kniffen; K P Qian; M S Urdea; C S Chan; M Mizokami; P D Neuwald; J C Wilber
Journal:  Lancet       Date:  1993-06-12       Impact factor: 79.321

7.  Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease.

Authors:  N Kato; O Yokosuka; K Hosoda; Y Ito; M Ohto; M Omata
Journal:  Hepatology       Date:  1993-07       Impact factor: 17.425

8.  Effect of iron overload on the response to recombinant interferon-alfa treatment in transfusion-dependent patients with thalassemia major and chronic hepatitis C.

Authors:  M G Clemente; M Congia; M E Lai; F Lilliu; R Lampis; F Frau; M R Frau; G Faa; G Diana; C Dessì
Journal:  J Pediatr       Date:  1994-07       Impact factor: 4.406

9.  Response to interferon alpha therapy is influenced by the iron content of the liver.

Authors:  D H Van Thiel; L Friedlander; S Fagiuoli; H I Wright; W Irish; J S Gavaler
Journal:  J Hepatol       Date:  1994-03       Impact factor: 25.083

10.  Magnetic resonance imaging and different levels of iron overload in chronic liver disease.

Authors:  E Rocchi; M Cassanelli; A Borghi; F Paolillo; M Pradelli; G Casalgrandi; A Burani; E Gallo
Journal:  Hepatology       Date:  1993-06       Impact factor: 17.425

View more
  13 in total

1.  Barriers to receiving hepatitis C treatment for people who inject drugs: Myths and evidence.

Authors:  Peter Higgs; Rachel Sacks-Davis; Judy Gold; Margaret Hellard
Journal:  Hepat Mon       Date:  2011-07       Impact factor: 0.660

Review 2.  Psychiatric and substance use disorders in individuals with hepatitis C: epidemiology and management.

Authors:  Jennifer M Loftis; Annette M Matthews; Peter Hauser
Journal:  Drugs       Date:  2006       Impact factor: 9.546

3.  Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies.

Authors:  Mohamed Hassan; Denis Selimovic; Abdelouahid El-Khattouti; Hanan Ghozlan; Youssef Haikel; Ola Abdelkader
Journal:  World J Exp Med       Date:  2012-04-20

4.  Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype.

Authors:  Sven G Gehrke; Wolfgang Stremmel; Inge Mathes; Hans-Dieter Riedel; Karin Bents; Birgit Kallinowski
Journal:  J Mol Med (Berl)       Date:  2003-10-14       Impact factor: 4.599

5.  Role of free radicals in liver diseases.

Authors:  Pablo Muriel
Journal:  Hepatol Int       Date:  2009-11-26       Impact factor: 6.047

6.  Hemochromatosis gene mutations: prevalence and effects on pegylated-interferon and ribavirin therapy response in chronic hepatitis C in sardinia.

Authors:  Margherita Sini; Orazio Sorbello; Alberto Civolani; Luigi Demelia
Journal:  J Clin Exp Hepatol       Date:  2012-09-21

Review 7.  Cocarcinogenic effects of alcohol in hepatocarcinogenesis.

Authors:  F Stickel; D Schuppan; E G Hahn; H K Seitz
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

Review 8.  HFE gene in primary and secondary hepatic iron overload.

Authors:  Giada Sebastiani; Ann-P Walker
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

Review 9.  Liver pathology of hepatitis C, beyond grading and staging of the disease.

Authors:  Sadhna Dhingra; Stephen C Ward; Swan N Thung
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

Review 10.  Hepatitis C virus-induced mitochondrial dysfunctions.

Authors:  Charlène Brault; Pierre L Levy; Birke Bartosch
Journal:  Viruses       Date:  2013-03-21       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.